Harnessing the benefits of available targeted therapies in acute myeloid leukaemia
Hagop Kantarjian, Nicholas J Short, Courtney DiNardo, Eytan M Stein, Naval Daver, Alexander E Perl, Eunice S Wang, Andrew Wei, Martin Tallman
Topics & Concepts
MedicineDecitabineAzacitidineHypomethylating agentMyeloid leukaemiaMidostaurinMyeloid leukemiaDaunorubicinVenetoclaxHomoharringtonineMyelodysplastic syndromesOncologyCytarabineInternal medicineFood and drug administrationPharmacologyMyeloidLeukemiaClinical trialClofarabineClinical researchAcute Myeloid Leukemia ResearchProtein Degradation and InhibitorsHedgehog Signaling Pathway Studies